High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma

EBioMedicine. 2020 Mar:53:102702. doi: 10.1016/j.ebiom.2020.102702. Epub 2020 Mar 19.

Authors

Caroline Louis-Brennetot¹, Olivier Delattre¹, Isabelle Janoueix-Lerosey²

Affiliations

¹ Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
² Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France. Electronic address: janoueix@curie.fr.

No abstract available

Publication types

Comment

MeSH terms

Humans
Hyaluronan Receptors
Neural Crest*
Neuroblastoma*
Prognosis

Substances

CD44 protein, human
Hyaluronan Receptors